- Home
- Companies
- usa massachusetts
- biomarker testing
Show results for
Refine by
Biomarker Testing Suppliers Serving Massachusetts
38 companies found
based inBelfast, UNITED KINGDOM
At Diaceutics we believe that every patient should have access to the right treatment at the right time. We provide the world’s leading pharmaceutical companies with an end-to-end solution for the launch of precision medicine diagnostics enabled by ...
What is DXRX Physician Mapping? DXRX Physician Mapping examines physician testing behavior (US only) using patient level data to determine testing rates, methodology and the physician to lab relationship. DXRX ...
based inNorthwood, OHIO (USA)
NAMSA is medical research organization providing expert regulatory, laboratory, clinical, and compliance services to medical device and healthcare product manufacturers. At every stage of the product development process, we provide strategic ...
We use our human skin model to test lead formulations and screen them against a variety of parameters in human skin to ensure clinical success. We perform antimicrobial efficacy testing, biomarker ...
based inPhoenix, ARIZONA (USA)
nVector enables and accelerates breakthrough treatments for previously untreatable diseases of the central nervous system. Iron Horse Diagnostics, Inc. is a privately held molecular diagnostic company focused on the development and commercialization ...
Amyotrophic Lateral Sclerosis (aka ALS or Lou Gehrig’s disease) is a devastating disease that is nearly always fatal within 5 years of onset. The symptoms are similar to many other neuropathies beginning with weakening of the limbs, leading to ...
based inClaymont, DELAWARE (USA)
CD Diagnostics is developing a series of diagnostic assays to rapidly detect the causes of joint pain using joint fluid analysis. We specialize in synovial fluid biomarker testing to aid in the diagnosis of joint infection (including Periprosthetic ...
CD Laboratories, a part of Zimmer Biomet, is a world leader in synovial fluid diagnostic testing solutions for patients suffering from joint pain and inflammation. Our highly specialized CLIA laboratory, located in Baltimore, MD, provides timely, ...
based inGosselies, BELGIUM
We are a genomic and theranostic company specializing in precision medicine for the treatment of patients with cancer and genetic diseases. OncoDNA is a company specializing in precision for the treatment of cancer and other genetic diseases. We are ...
Order OncoDNA's solutions, browse your patients' history and receive your personalised report on treatment recommendations. When you join OncoSHARE, you become a member of an active network gathering together more than 13,000 patients and ...
based inBillerica, MASSACHUSETTS (USA)
We are on a mission to change the way in which healthcare is provided by giving researchers the ability to closely examine the continuum from health to disease. In order to make this vision a reality, we brought together the most experienced ...
based inEdmonton, ALBERTA (CANADA)
Nanostics is a medical device and biotechnology company with a mission to provide clarity to people about their health by enabling better diagnosis and improving health care decisions through machine learning and extracellular vesicle detection. ...
Our core technology ClarityDX® can: Identify biomarkers expressed by diseased cells/tissues. Indicate if treatment is needed. Predict treatment response and resistance. Stratify disease stage. Identify disease ...
based inHollister, CALIFORNIA (USA)
For 70 years, Charles River employees have worked together to assist in the discovery, development and safe manufacture of new drug therapies. When you join our family, you will have a significant impact on the health and well-being of people across ...
based inWaltham, MASSACHUSETTS (USA)
Exosome Diagnostics, Inc. is commercializing minimally invasive molecular diagnostics in blood and urine to enable doctors to select optimal therapies for cancer and other diseases. Exosomes are lipid bilayer covered microvesicles shed by solid ...
After marker identification, biomarkers and/or gene signatures enter our development process to become targeted assays. The newly identified biomarkers are developed into a Laboratory Developed ...
based inMechelen, BELGIUM
Biocartis is an innovative molecular diagnostics company committed to revolutionize molecular testing with its unique proprietary IdyllaTM platform. We provide next generation diagnostic solutions, aimed at improving clinical practice for the ...
The fully automated Idylla EGFR Mutation Test covers 51 mutations in exons 18–21 in a single cartridge using only 1 FFPE tissue section from metastatic NSCLC showing a high concordance of >95% compared with reference ...
based inFort Myers, FLORIDA (USA)
NeoGenomics is a premier cancer diagnostic, pharma services, and information services company serving oncologists, pathologists, pharmaceutical companies, and academic centers in their pursuit of providing better futures for people living with ...
Our genomics laboratories in La Jolla, California (formerly Human Longevity Oncology), and Houston, Texas (formerly SeqWright Genomics), are outfitted for high throughput genomics. In addition to our molecular menu of validated assays spanning ...
based inRostock, GERMANY
Since 2006, CENTOGENE has helped physicians diagnose thousands of rare disease patients around the world. A quick and accurate diagnosis can end an odyssey of medical tests and visits to multiple medical specialists. It also helps physicians better ...
Genetic testing is a type of medical test that identifies changes in genes, inherited from our parents, which we then typically pass on to our children. “Mistakes” in our genes (called “pathogenic variants”) can manifest the ...
based inHayward, CALIFORNIA (USA)
Novodiax is dedicated to advancing tissue-based diagnostics and immunoassays through innovation. Our signature technology platform is a proprietary polymer-based detection system. Based on this technology we have developed a series of highly ...
Cluster of Differentiation 20 (CD20) is a polymerized horseradish peroxidase (pHRP)-labeled anti-CD20 (R272) rabbit monoclonal antibody intended for laboratory use using frozen or formalin-fixed-paraffin-embedded tissues. CD20 also known as ...
based inWokingham, UNITED KINGDOM
SGS M-Scan is a world leading group of chemical analysis laboratories specialized in chemical testing as well as high-end GLP/GMP contract analytical services, consultancy and training based on Mass Spectrometry and ...
In collaboration with the clinical team, SGS has actively pursued innovative biomarker assay development and validation. To complement our range of immunoassays, we are now offering LC-MS/MS technology that has enabled us to extend our portfolio to ...
based inBend, OREGON (USA)
Empowering People Through Optimal Health. At Optimal DX, our mission is to constantly instill the most recent and effective medical findings into our products and services so that practitioners can complete their mission: improving their patients’ ...
The optimal range of a given blood biomarker is a narrow band of upper and lower limits that correspond to the optimally healthy levels for that biomarker. In contrast to the “normal” reference ranges used in allopathic medicine, the ...
based inSeattle, WASHINGTON (USA)
Nexelis is your partner for assay and biomarker development, advanced bioanalytical and laboratory testing, and translational immunology. As the leading specialty laboratory, we have unrivaled expertise in immunology, specifically in the areas of ...
Testing Services to Support Your Preclinical and Phase I-IV Drug Programs. Nexelis, a Q² Solutions Company, provides biomarker assay services in inflammation and immunology, oncology, organ injury (renal), ...
based inAustin, TEXAS (USA)
Vigilant Biosciences is a leading innovator and developer of solutions that aid in the early detection of oral cancer. Our point–of–care solution is simple, accurate† and cost–effective–empowering clinicians to improve potential outcomes through ...
based inBeverly, MASSACHUSETTS (USA)
Cellanyx is a growth stage emerging biotech advancing proprietary phenotypic (appearance and dynamics) biomarker tests based on Machine Vision and AI-driven analysis of live single tumor cells to improve risk-stratification and shared clinical ...
based inCortlandt Manor, NEW YORK (USA)
Polymedco is dedicated to enhancing early detection of life-threatening diseases as healthcare challenges intensify due to rising chronic disease rates, an aging population, and soaring medical costs. The company collaborates with healthcare ...
The PATHFAST Analyzer is designed to enhance cardiac care in emergency department settings by providing high-sensitivity cardiac troponin (hs-cTn) and NT-proBNP testing capabilities. This compact, benchtop device delivers rapid, lab-quality results ...
based inEschborn, GERMANY
When we looked at the decision making landscape in organizations and observed that the available technologies and models were helping make decisions but with fixed cycles of information processing, running in batches, with little flexibility and ...
Identify the biomarkers best suited for your needs: Diagnose rare or ambiguous diseases, Group patients by endotype response for prognosis, Assess disease etiology to determine responsive patient group ...